Beware flammable components in emollient products

Emollients are moisturisers applied to the skin to soothe and hydrate, covering the skin with a protective film to trap in moisture.  The British Medicines and Healthcare products Regulatory Agency (MHRA) is recommending that labelling and product information for...

Polypharmacy update

An excellent review of the current state of knowledge about the effects of polypharmacy has recently been published in Expert Opinion on Drug Safety – the original resource can be viewed...

Cystic fibrosis presents many serious therapeutic challenges: Kingsley Coulthard has recently reviewed novel therapies used for CF, and addresses remaining challenges. Read more here.

What is idelalisib: a practical review

Idelalisib is a potent oral selective inhibitor of phosphatidylinositol 3‐kinase p110δ, approved in Australia for the treatment of relapsed chronic lymphocytic leukaemia and small cell lymphocytic lymphoma in combination with rituximab or ofatumumab in patients for...